| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.06 | 0.5 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |